Miguel Barclay has built a reputation on proving that good food doesn’t need to cost more than £1 a portion. Now, he’s ...
His latest project, in collaboration with Novo Nordisk UK, is a collection of seven ... The takeaway is to swap white rice for brown, sugary cereals for oats and make fibre your best friend.
The 'big three' insulin producers Novo Nordisk ... including Hispanic and Black people, who are much more likely to be diagnosed with diabetes than non-Hispanic white people - and much more ...
But as the drugstore chain (WBA) prepares to go private and its rival CVS Health Inc. (CVS) experiments with smaller stores, some analysts and researchers see a possible future with even fewer ...
Rain sales on Big Tech stocks that overwhelm the Nasdaq but also infect the European lists. At Piazza Affari Buzzi and the ...
Novo Nordisk faces formidable challenges from Eli Lilly and new rivals, but its first-mover advantage and expanded ...
In a report released today, Jo Walton from UBS maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price target of ...
Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...
Novo Nordisk (NVO) stock rebounds after Kepler Cheuvreux upgrades to Buy following a 42% stock drop over the past year. Read ...
Novo Nordisk (NVO), the company behind popular diabetes and obesity treatments Ozempic and Wegovy, saw its stock rise on Thursday after ...
Roche agreed to develop a weight-loss drug with Danish biotech Zealand Pharma, pressuring Novo Nordisk and Eli Lilly.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results